article thumbnail

Allergan Aesthetics and BOTOX® Cosmetic (onabotulinumtoxinA) Put Real Stories at the Forefront in New Campaign

The Pharma Data

June 8, 2021 /PRNewswire/ — Allergan Aesthetics, an AbbVie company (NYSE: ABBV ), is changing the way BOTOX ® Cosmetic, the #1 selling neurotoxin treatment 1 , is connecting with consumers. “BOTOX ® Cosmetic is honoring and celebrating the dynamic people who use our products. IRVINE, Calif.

Botox 52
article thumbnail

Want to Join a Women’s Health Research Study? This May be Your Chance to Contribute to UUI Solutions

Trialfacts

More Study Details About the Research Center Study Location Research Center: Howard University College of Medicine Location: Howard University Hospital, 2041 Georgia Avenue NW. The goal of this study is to compare two treatments: Mirabegron or Vibegron (oral medications) versus Botox A® (an injected medication).

Botox 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AbbVie to Highlight Its Leadership in Movement Disorders at the.

The Pharma Data

“Our research presented at MDS 2021 builds upon our expertise in neuroscience and reinforces our mission to advance the standards of care for people living with these debilitating diseases.” BOTOX ® Abstracts. BOTOX ® (onabotulinumtoxinA) Important Information.

Botox 52
article thumbnail

U.S. FDA Accepts AbbVie’s New Drug Application for Atogepant for the Preventive Treatment of Migraine

The Pharma Data

2] – The atogepant application demonstrates AbbVie’s longstanding commitment to providing multiple migraine treatment options, including BOTOX® (onabotulinumtoxinA), a preventive treatment for those with chronic migraine, and UBRELVY® (ubrogepant), an acute treatment for adults with migraine. IMPORTANT SAFETY INFORMATION.

Botox 52
article thumbnail

Neuroscience Portfolio at the 2021 American Academy of Neurology (AAN) Annual Meeting

The Pharma Data

Researchers will present data from several studies on migraine, including new findings on atogepant, AbbVie’s investigational preventive treatment of migraine in adults who meet criteria for episodic migraine as well as results evaluating the efficacy and safety of BOTOX ® (onabotulinumtoxinA) and UBRELVY ® (ubrogepant).

Botox 52
article thumbnail

Ipsen’s John Chaddock on making neurotoxins a priority for healthcare systems

pharmaphorum

Ipsen’s John Chaddock tells us why the company is investing heavily in neurotoxin research and how he hopes to raise awareness among young scientists and the NHS. One such expert is John Chaddock, VP head of research, external innovation & early development at Ipsen. Now, he says, neurotoxin research is truly global.

Botox 105
article thumbnail

Aesthetic Alchemy: “Artistry of Medical Aesthetic Procedures”

Roots Analysis

Medical Aesthetics is an area of modern medicine that specializes in improving the outer appearance of an individual without surgery. In fact, medical aesthetics companies are also investigating the effects of “Baby Botox” given in lower concentrations to provide more subtle results. It is worth noting that in 2022, more than 7.4

Filler 40